Natasha Salant

Natasha joined the Health Economics Research Centre (HERC) in September 2023. Her current research focuses on the EU-funded REVERSE (pREVention and management tools for rEducing antibiotic Resistance in high prevalence SEttings) project, which aims to develop affordable and cost-effective strategies and tools for the prevention and clinical management of healthcare-associated infections due to antimicrobial resistance. She is also conducting research to evaluate the economic and epidemiological consequences of vaccine implementation strategies for chikungunya. 

Prior to joining HERC, Natasha worked as a health economist in the Centre for Guidelines at the National Institute for Health and Care Excellence (NICE) where she conducted evidence reviews and developed models to assess the cost-effectiveness of clinical guidelines. 

Previously, Natasha worked at the Clinton Health Access Initiative in Rwanda and South Africa where she worked with governments on health financing and health system strengthening. Natasha holds a MPhil in Population Health Sciences from the University of Cambridge.